Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.00 (0.00%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

18 Aug 2021 10:10

RNS Number : 0239J
Tate & Lyle PLC
18 August 2021
 

Tate & Lyle PLC

Notification of transaction by a Person Discharging Managerial Responsibilities

Tate & Lyle PLC (the 'Company') has been informed that on 12 August 2021, Jim Stutelberg, a Person Discharging Managerial Responsibilities, sold 110,000 ordinary shares of 25 pence each in the capital of the Company ('Shares') at a sale price of 730.01 pence per Share.

 

Mr. Stutelberg continues to comply with the Executive Shareholding Policy of three times base salary.

 

The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Claire-Marie O'Grady

Company Secretary

18 August 2021

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jim Stutelberg

2.

Reason for the notification

a)

Position / status

President, Primary Products

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b)

Nature of the transaction

Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£7.3001

110,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

110,000

 

£803,011

e)

Date of the transaction

2021-08-12

f)

Place of the transaction

London Stock Exchange

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWAWRASUWARR
Date   Source Headline
15th May 20263:11 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20262:53 pmRNSForm 8.3 Tate & Lyle Plc
15th May 20262:35 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
15th May 20261:52 pmRNSForm 8.3 Tate & Lyle plc
15th May 20261:15 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 20261:14 pmRNSForm 8.5 (EPT/NON-RI)- TATE & LYLE PLC
15th May 20261:11 pmRNSForm 8.5 (EPT/NON-RI)-TATE & LYLE PLC
15th May 20261:10 pmRNSForm 8.3 TATE & LYLE PLC
15th May 202612:51 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 202612:28 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Opening Position disclosure
15th May 202612:23 pmRNSForm 8.3 - Tate & Lyle plc
15th May 202611:53 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:35 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:29 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:28 amGNWForm 8.3 - TATE & LYLE PLC
15th May 202611:28 amBUSForm 8.3 - TATE & LYLE PLC
15th May 202611:25 amRNSForm 8.3 - Tate & Lyle PLC
15th May 202611:20 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:09 amRNSForm 8.3 - Tate & Lyle plc
15th May 202611:06 amRNS20260514_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
15th May 202611:04 amRNS20260514_TATE & LYLE_8.5 EPT RI_UK_MLI
15th May 202610:56 amRNSForm 8.3 Tate & Lyle PLC
15th May 202610:49 amPRNForm 8.3 - Tate & Lyle PLC
15th May 202610:24 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 202610:24 amBUSDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 20268:56 amRNSForm 8.5 (EPT/RI)
14th May 20264:15 pmRNSPossible 595 pence all-cash offer for Tate & Lyle
14th May 20263:25 pmRNSForm 8.3 - Tate & Lyle plc
14th May 20261:24 pmRNSDisclosure Table
14th May 20261:07 pmRNSStatement re Possible Offer for Tate & Lyle
1st May 202610:00 amRNSTotal Voting Rights
1st Apr 20264:00 pmRNSHolding(s) in Company
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.